By selecting competitive, non-transported inhibitors of SLC36A1 from this study, we performed a whole-animal Drosophila screen to identify candidates that suppress tumour growth and display minimal whole-animal toxicity. The gene discussed is SLC36A1; the disease is neoplasm.